CIK 0001370053 · Non-accelerated filer<br>Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203828755
- Phone
- 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +9,200 | 9,200 | ||
| 2026-04-20 | Faga Daniel President, CEO | Returned to the company · Employee Stock Option (right to buy) | −194,900 | 194,900 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +194,900 | 194,900 | ||
| 2026-04-20 | Faga Daniel President, CEO | Returned to the company · Employee Stock Option (right to buy) | −379,620 | 379,620 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +379,620 | 379,620 | ||
| 2026-04-20 | Faga Daniel President, CEO | Returned to the company · Employee Stock Option (right to buy) | −305,500 | 305,500 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +305,500 | 305,500 | ||
| 2026-04-20 | Faga Daniel President, CEO | Returned to the company · Employee Stock Option (right to buy) | −133,400 | 133,400 | ||
| 2026-04-20 | Faga Daniel President, CEO | Grant or award · Employee Stock Option (right to buy) | +133,400 | 133,400 | ||
| 2026-04-20 | Schmid John P. Director | Returned to the company · Stock Option (right to buy) | −15,000 | 15,000 | ||
| 2026-04-20 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2026-04-20 | Schmid John P. Director | Returned to the company · Stock Option (right to buy) | −6,000 | 6,000 | ||
| 2026-04-20 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2026-04-20 | Schmid John P. Director | Returned to the company · Stock Option (right to buy) | −6,000 | 6,000 | ||
| 2026-04-20 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2026-04-20 | Schmid John P. Director | Returned to the company · Stock Option (right to buy) | −11,000 | 11,000 | ||
| 2026-04-20 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2026-04-20 | Schmid John P. Director | Returned to the company · Stock Option (right to buy) | −11,000 | 11,000 | ||
| 2026-04-20 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2026-04-20 | Schmid John P. Director | Returned to the company · Stock Option (right to buy) | −9,200 | 9,200 |
Page 2 of 17 · 339 trades